Immune cells boost cancer survival from months to years

Firms embrace costly immunotherapy to fight intractable leukaemias and lymphomas.

Article contraptions

Therapies that make use of a patient’s own T cells, a component of the immune system, are displaying promise in the clinic.

When immunologist Michel Sadelain launched his very first trial of genetically engineered, cancer-fighting T cells in 2007, he struggled to find patients willing to participate. Read more